MREM Press Releases
GBI Certification System Goes Online
KUALA LUMPUR, Dec 13 (Bernama) — Greenbuildingindex Sdn Bhd (GSB), which owns and administrates Malaysia’s premier and international green rating tool for buildings and townships – Green Building Index (GBI) – has launched its online system to facilitate the various GBI certification processes. Aptly named “GreenUp”, the online certification system was uploaded
AGC Biologics and Gore Collaborate on New Protein A-based Purification Technology and Contract Manufacturing Services for Antibody Therapies
Seattle, Dec 13 (Bernama-GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a collaboration with W.L. Gore & Associates (Gore) that features Protein A affinity purification technology from Gore alongside the CDMO’s contract development and manufacturing services. By using GORE and AGC
PETRONAS, Emerson to Collaborate on Digital Transformation and Decarbonisation Initiatives
KUALA LUMPUR, Dec 13 (Bernama) — PETRONAS has recently inked a Memorandum of Understanding (MoU) with global technology and software company, Emerson to drive digital transformation and decarbonisation initiatives. The two companies are building on their decades-long relationship to develop advanced automation solutions. Over the past few years, Emerson has
NTHU Team Wins Championship At SCC
HSINCHU, Taiwan, Dec 13 (Bernama-BUSINESS WIRE) — A student team from the Department of Computer Science at National Tsing Hua University (NTHU) in Taiwan has recently won the championship at the World Supercomputer Student Cluster Competition (SCC) held in Dallas, USA. This was the fifth championship won by an NTHU team
SaVia Health Raises $8.5 Million Seed Round To Optimize Patient Care Pathways
SALT LAKE CITY, Dec 13 (Bernama-BUSINESS WIRE) — SaVia Health, a clinician-led healthcare SaaS company that creates and embeds patient care processes alongside electronic medical records (EMR), announced it raised an $8.5 million Seed round. The round was led by Intel Capital with participation from Kickstart, Peterson Ventures, Tom Burton, the
actyv.ai appoints Sanjeev Chhabra as Chief Growth Officer to drive global expansion
BENGALURU, India, Dec 13 (Bernama-BUSINESS WIRE) — actyv.ai, a category creator in the enterprise SaaS with embedded B2B BNPL and insurance space, has announced the appointment of Sanjeev Chhabra as its Chief Growth Officer to drive global expansion. Sanjeev Chhabra, an IIT (Bombay) and IIM (Ahmedabad) alumnus, is a corporate
MCKL Students Lauded As Outstanding Cambridge Learners Awards
KUALA LUMPUR, Dec 13 (Bernama) — Five students from the Cambridge A Level programme at Methodist College Kuala Lumpur (MCKL) were recognised as outstanding performing learners in Malaysia, and globally, in the June 2022 examination series. In announcing the results, the students were honoured at the Outstanding Cambridge Learner Awards ceremony,
Fuzhou, a Green City with Harmonious Integration of Nature and Industry, Ecological and Modernized Development
FUZHOU, China, Dec 13 (Bernama-AsiaNet) — Recently, the promotional video of Fuzhou of Fujian Province, titled “The Fuzhou Waiting for You to Explore — Green Economy”, was released through overseas social media accounts including “Paris Oriental Center”, “Discover Fujian” and “Discover Fuzhou”, showing the world Fuzhou, a green city with
Rapid Recovery in Non-Gloves Latex Products Exports
KUALA LUMPUR, Dec 13 (Bernama) — Total exports of rubber products up to the third quarter of 2022 were RM21.858 billion compared to RM52.204 billion in the previous year. Meanwhile, the export of rubber in 2021 was RM6.872 billion, with an increase of 0.16% for the year 2022, this totaled
Tessa Therapeutics Announces New Clinical Data from Phase 1 Allogeneic Study Presented at 2022 Annual Meeting of American Society of Hematology (ASH)
SINGAPORE, Dec 12 (Bernama-GLOBE NEWSWIRE) — Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced enhanced clinical data from an ongoing Phase 1 study (NCT04288726) of TT11X, an allogeneic “off the shelf” CD30.CAR-modified Epstein-Barr virus-specific T-cell (EBVST) therapy being co-developed